Figure 3.Mutation status of METTL16 across TCGA tumors. (A) The alteration frequency with mutation type. (B) Mutation site (C) The association between mutation and OS (Overall survival), PFS (Progression-free survival) and DSS (Disease-specific survival). (D) A Spearman association between METTL16 CNV and mRNA was performed in pan-cancer.
